Q2 2023 · 13F-HR
Madison Avenue Partners, LPholdings as filed
Filed 2023-08-14 · accession 0001801265-23-000005
$458.3M
Reported value
19
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 384637104 | GHC | GRAHAM HLDGS CO | $114.6M | 25.0% | 200,484 | Common | SOLE |
| 36237H101 | GIII | G III APPAREL GROUP LTD | $75.4M | 16.5% | 3,914,869 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $72.6M | 15.8% | 7,012,226 | Common | SOLE |
| 85256A109 | STGW | STAGWELL INC | $51.5M | 11.2% | 7,147,662 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HLDS C | $38.0M | 8.30% | 924,667 | Common | SOLE |
| 68629Y103 | ONL | ORION GROUP HLDGS INC | $27.1M | 5.91% | 4,095,901 | Common | NONE |
| 320517105 | FHN | FIRST HORIZON CORPORATION | $20.8M | 4.53% | 1,843,065 | Common | SOLE |
| 57638P104 | MBC | MASTERBRAND INC | $15.1M | 3.30% | 1,298,688 | Common | SOLE |
| 717098206 | — | PFSWEB INC | $11.9M | 2.60% | 2,633,189 | Common | NONE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $10.8M | 2.37% | 3,307,605 | Common | SOLE |
| 590328209 | MACKEUR | MERRIMACK PHARMACEUTICALS INC | $6.8M | 1.48% | 553,085 | Common | SOLE |
| 55262C100 | MBI | MBIA INC | $3.6M | 0.79% | 420,826 | Common | SOLE |
| 35471R106 | FSP | FRANKLIN STR PPTYS CORP | $2.9M | 0.63% | 2,002,653 | Common | SOLE |
| 153436100 | CEE | CENTRAL & EASTERN EUROPE FD | $1.9M | 0.42% | 211,030 | Common | SOLE |
| 871332102 | SLVM | SYLVAMO CORP | $1.6M | 0.35% | 40,163 | Common | SOLE |
| 52634L108 | LNSR | LENSAR INC | $1.5M | 0.33% | 357,463 | Common | SOLE |
| G5005R107 | JRVR | JAMES RIV GROUP LTD | $1.2M | 0.25% | 63,887 | Common | SOLE |
| 786449207 | — | SAFEGUARD SCIENTIFICS INC | $645,906 | 0.14% | 391,459 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $266,560 | 0.06% | 11,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.